In June 2021, Dr. Tedros Ghebreyesus, offered a challenge to the world: “To truly end the pandemic, our goal must be to vaccinate at least 70 percent of the world’s population by the time you meet again in Germany next year.” However, as we approach this year’s G7 summit, the 70 percent target has b...

In May, the World Bank issued a white paper on a new financial intermediary fund (FIF) for pandemic prevention, preparedness, and response. This document will be the basis for subsequent discussion and approval by the World Bank’s Board, composed of 25 constituencies representing 189 country governm...

On May 12, the White House will co-host the Second Global COVID-19 Summit—alongside the governments of Belize, Germany, Senegal, and Indonesia. The (virtual) convening comes more than seven months after a US-organized meeting last September that was intended to spur global action to bring an end to ...

In a new paper, we reflect on the current landscape of MCM manufacturing, share lessons learned amid COVID-19, and offer recommendations to the global community to fund MCM purchases on day-zero of the next pandemic.

Tuberculosis, once highly prevalent across Europe and North America, has largely been forgotten in the West but remains a heavy burden in low- and middle-income countries. Now, as rich countries vaccinate (and boost) their populations against COVID-19, lift restrictions, and slowly return to “normal...

While oral antivirals are not a substitute for vaccination, they help prevent severe illness, save lives, and preserve health systems. Vaccination rates continue to lag in low-income countries: only 14 percent of the population in low-income countries has received one dose of the vaccine, compared t...

The reaction to COVID-19 has been record-breaking. Today we release a paper that reports on the development and rollout of COVID-19 vaccines in historical perspective, and it suggests a pattern of unparalleled, but still deeply inequitable, progress.